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Porphyria cutanea tarda (PCT) requires long-term 
treat ment and follow-up, although many patients ex-
perience life-long remission. The aim of this cross-sec-
tional postal survey was to describe and investigate 
the association between illness perception, health 
complaints, self-reported symptoms and distress in 
persons with PCT. The participants perceived PCT as 
a chronic condition with high levels of personal and 
treatment control. Persons who reported active symp-
toms scored higher on perceived illness threat, total 
health complaints and psychological distress compa-
red with those in remission or latent phases. However, 
a higher perception of illness threat and the total bur-
den of health complaints were more closely associated 
with psychological distress than were perceived PCT 
symptoms activity. This has implications for clinical 
consultation; dermatologists should be attentive to 
symptoms activity, but also recognize that patients in 
remission with a high perceived illness threat and mul-
tiple health complaints might be especially vulnera-
ble to psychological distress with regards to PCT. Key 
words: porphyria cutanea tarda; illness perception; 
psychological distress; subjective health complaints; 
psychosocial.
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Porphyria cutanea tarda (PCT) is the most common form 
of the porphyrias, a group of rare and mainly inherited 
metabolic diseases caused by reduced enzyme activity 
in the haem synthetic pathway (1). The prevalence is 
estimated at 1 in 10,000 (2), and approximately 50% of 
cases in Norway are hereditary, with a 10% penetrance 
(3). PCT symptoms usually present in late adulthood as 
skin fragility, blistering, milia, hypertrichosis and in-
creased pigmentation on sun-exposed areas, and can be 
triggered by iron overload, hepatic conditions, oestrogens 
and high alcohol intake. Treatment includes avoidance 
of precipitating factors, phlebotomy and/or administra-
tion of chloroquine (1, 4). Complete clinical remission 
can take up to 6–12 months (5, 6), but the prognosis is 
good, and lifelong remission is common. Guidelines sug-
gest that urinary porphyrin concentration, iron and liver 
function should be assessed annually in order to detect 
relapses (1, 4). Patients in biochemical remission have 
normal tolerance for sunlight.
Very little is known about the subjective experiences 
of PCT and, to our knowledge, only 2 previous research 
reports have focused on the psychosocial aspects of 
PCT. Jong et al. (7) found that PCT had less impact on 
quality of life (QoL) than did other cutaneous porphyrias 
and photodermatoses in general. However, only 12 per-
sons with PCT participated in the study, and the results 
should therefore be interpreted with caution. In contrast, 
a previous qualitative study found that PCT symptoms 
at their worst could be very dramatic and have a large 
psychosocial impact. The participants had a perception 
of the condition as systemic and chronic, and had a ten-
dency to attribute a range of health problems to PCT. 
There were also reports of over-treatment, and frequent 
controls for patients in long-term remission (8). PCT 
patients are a heterogeneous group, comprising persons 
with active symptoms, those in remission and asympto-
matic mutation carriers (latent PCT), and they require 
various degrees of treatment and long-term follow-up. 
To optimize patient care it is, therefore, important to 
expand our understanding of how PCT is perceived and 
experienced by the patients themselves.
The aims of the present study were: (i) to describe 
and compare illness perception, self-reported health 
complaints and psychological distress in persons with 
various activity of PCT; and (ii) to examine the asso-
ciations between illness perception, self-reported health 
complaints, PCT symptoms, and psychological distress.
PATIENTS AND METHODS
Design
A cross-sectional survey comprising a battery of self-evaluative 
questionnaires was posted to all persons older than 18 years with 
PCT registered at the Norwegian Porphyria Centre (NAPOS). The 
study was approved by the Norwegian Regional Ethics Commit-
tee (2010/1140) and complies with the Declaration of Helsinki.
Sample and recruitment
NAPOS conducts nationwide diagnostics based on biochemical 
and DNA analysis in addition to predictive genetic testing. Almost 
all persons with a known porphyria diagnosis in Norway are regis-
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tered at NAPOS. Participants were recruited by NAPOS in May 
2010. Follow-up reminders were sent to non-responders in June 
and October the same year. Diagnosis was based on analysis of 
urinary and faecal porphyrins in addition to plasma fluorescence 
scanning and uroporphyrogen decarboxylase (UROD) DNA ana-
lysis according to established criteria (9). “Sporadic” PCT patients, 
for whom porphyria analysis had not been performed in the past 10 
years, were excluded from the study, based on the assumption that 
they had not experienced any PCT symptoms in the past 10 years.
Participants were categorized as having active PCT (porphyria 
symptoms in the day or week of the survey), PCT in remission 
(previous symptoms, but not at present) or latent PCT (mutation 
carriers who had never experienced PCT symptoms). Categoriza-
tion was based on self-reports and was assessed by the following 
question in the questionnaire: “Have you had any porphyria-related 
complaints/symptoms?” followed by the answer categories: 1, 
never; 2, previously; and 3, have today/this week.
Measures
Socio-demographic characteristics. The socio-demographic 
variables included sex, age, work status, educational level, coha-
bitation status and having children. 
Patient-reported outcome measures
Illness perception. The Brief Illness Perception Questionnaire 
(BIPQ) (10, 11) assesses the illness representations as adapted 
from the common sense model of Leventhal et al. (12) and has 
satisfactory validity and reliability. The questionnaire comprises 
8 items measuring different dimensions of illness perception: con-
sequences, timeline, personal control, treatment control, identity 
concern, emotions and coherence (illness comprehensibility). 
Identity refers to the symptoms a person views as part of the di-
sease. Responses are measured on a 0–10-point scale. An overall 
score was computed by summing across the 8 items. Higher scores 
reflect a higher perceived threat associated with the condition (13).
Self-reported health complaints. The Subjective Health Com-
plaints (SHC) inventory measures self-reported health complaints 
during the past 30 days on a 0–3 point Likert scale and without 
mapping the diagnosis or symptom attributions. The instrument 
is a 29-item scoring system that is categorized into 5 factors: 
musculoskeletal, pseudoneurology, gastrointestinal, allergy, and 
influenza complaints (14, 15). The instrument has satisfactory 
reliability and validity (15). In the present study, only the mean 
total sum score was assessed.
Porphyria-related psychological distress. The Impact of Events 
Scale (IES) measures psychological distress defined as the de-
gree of impact of a specific event experienced at present, in this 
instance, porphyria. The responses are measured on 2 subscales: 
intrusion and avoidance. Intrusion is characterized by unbidden 
thoughts and strong waves of feelings, and avoidance includes 
denial of the meanings and consequences of the event. The scale 
comprises 15 items: 7 on intrusion and 8 on avoidance. The re-
sponses are assessed on a 0–5-point Likert scale. The psychometric 
properties have been found to be satisfactory (16, 17). 
Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics 
Version 22.0 (Armonk, NY, USA). Most analyses were based on 
the 3 subgroups: active, remission and latent PCT. If more than 
50% of the items were missing, the sum scores were not calculated 
for the IES subscales and the SHC inventory total (15). When 
calculating the overall score on the BIPQ, items 3, 4 and 7 were 
reversed according to the manual. If any items were missing on 
the BIPQ, the overall score was not calculated (13). 
Differences in socio-demographic variables were investigated 
using Pearson’s χ2 test for independence for categorical variables. 
Separate 1-way Welch analysis of variance (ANOVA) was used to 
determine whether the scores on the BIPQ, SHC and IES subscales 
differed between the 3 PCT subgroups. There were some outliers 
and non-normality. As a sensitivity test we used a Kruskal–Wallis 
non-parametric test, which identified the same significant outcome 
measures as the ANOVA. 
To investigate the associations between illness perceptions, 
self-reported health complaints and porphyria-related psycholo-
gical distress, 2 separate multiple linear regression analyses were 
conducted. The IES subscales intrusion and avoidance were the 
dependent variables and age, sex, SHC inventory total score, BIPQ 
total score and perceived PCT symptoms were entered as the 
predictors in the models. PCT symptoms were dichotomized into 
present symptoms (active PCT) or not present symptoms (remis-
sion and latent PCT). Twenty and 27% of the participants scored 
a total of 0 on the intrusion and avoidance subscales, respectively, 
thus creating a “floor effect”. To meet the assumption of norma-
lity, those participants scoring a total of 0 on the IES subscales 
were removed from the multiple linear regression analysis. This 
resulted in a total of 185 (IES intrusion subscale) and 168 (IES 
avoidance subscale) for the regression analysis. Those scoring 
0 on the subscales were distributed as follows: intrusion: active 
symptoms, n = 6, not active symptoms, n = 51; avoidance: active 
symptoms, n = 7, not active symptoms, n = 61. The assumptions of 
linearity, independence of errors, homoscedasticity and extreme 
outliers were met. Violation of the assumption of normality of 
residuals was addressed through logarithmic transformation of 
the outcome measure variables.
To investigate the likelihood of scoring 0 or > 0 on the IES 
subscales, logistic regression analyses were performed, using the 
same predictors and dependent variables as were specified in the 
multiple linear regression analyses.
RESULTS
A total of 484 persons registered with PCT were sent a 
postal questionnaire, and 272 were returned (56%). Nine 
participants were excluded from further analysis because 
of a missing response to the question categorizing partici-
pants into having active PCT, PCT in remission or latent 
PCT. A total of 263 (54%) questionnaires were eligible 
for further analysis.
Socio-demographic characteristics
Of the 263 respondents, 57 reported having present active 
PCT, 172 had PCT in remission and 34 reported latent 
PCT. For the total sample, the mean age was 59 years 
(range 25–88 years). Significant socio-demogra phic dif-
ferences were found between the groups with regards to 
sex, age, and occupational and educational status. The 
active PCT group had more men than women, and the la-
tent group had considerably more women. The mean age 
was >10 years younger in the latent PCT group than in 
the remission and active groups. For occupational status, 
70% of the latent group reported being employed com-
pared with 33% of the active group. Higher percentages 
of the active and remission groups than the latent group 
claimed disability benefits or were retired (Table I).
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Patient-reported outcome measures
The total sample scored > 8 on the timeline item on the 
BIPQ, indicating a high belief in the condition being 
chronic. The active PCT group had significantly higher 
perceived illness threat compared with the other PCT 
subgroups. They also had considerably higher mean 
scores on the identity item, meaning that they belie-
ved more symptoms were caused by PCT compared 
with remission and latent PCT. The total sample had 
a relatively high perception of coherence and personal 
control. On the treatment control item, the total sam-
ple scored even higher; although the remission group 
scored highest.
The active PCT group had a significantly higher 
mean score on total intensity and frequency of 
subjective health complaints compared with the 
remission and latent PCT subgroups. The active 
PCT group had a higher mean value on reported 
psychological distress (intrusion and avoidance) 
than the remission subgroup, which had a higher 
mean score than the latent group (Table II).
Associations between illness perception, health 
complaints, self-reported porphyria cutanea 
tarda symptoms and psychological distress
When investigating the associations between ill-
ness perception, health complaints, self-reported 
PCT symptoms and psychological distress, we 
found that illness perception and total score on 
subjective health complaints were significantly as-
sociated with a higher score on the intrusive scale 
and that the total model explained 30% of the vari-
ance. The same predictors were also significantly 
associated with the avoidance score and explained 
20% of the variance. The self-reported presence of 
PCT symptoms were not significantly associated 
with psychological distress related to porphyria (Table 
III). This means that al though participants reporting ac-
tive PCT scored higher on perceived illness threat, total 
health complaints and porphyria-related psychological 
distress, PCT symptoms activity was not significantly 
associated with psychological distress.
We used the same predictors to investigate the proba-
bility of scoring > 0 on the IES avoidance and intrusion 
scales. Logistic regression analysis produced a significant 
model that confirmed that a higher score on total illness 
perception and more self-reported health complaints were 
significantly associated with scoring > 0 on porphyria-
related psychological distress.
Table I. Socio-demographic characteristics of the sample





n = 57 (22)
In remission 
 n = 172 (65)
Latent 
n = 34 
(13)
Sex
  Male 121 (47) 34 (60) 78 (46) 9 (27)
  Female 141 (53) 23 (40) 93 (54) 25 (73) 0.01*
Age, years   59 (25–88) 61 (29–87) 60 (25–88) 49 (31–87) < 0.01*
Occupational status
  Working 117 (44) 19 (33) 74 (43) 24 (70)
  Retired 77 (30) 18 (32) 56 (33) 3 (9)
  Disability pension 54 (20) 14 (25) 36 (21) 4 (12)
  Other 15 (6) 6 (10) 6 (3) 3 (9)  < 0.01*
Educational status
  Secondary school 58 (23) 10 (18) 45 (27) 3 (8)
  High school 117 (45) 32 (56) 71 (42) 14 (41)
  College/university 84 (32) 15 (26) 52 (31) 17 (50) 0.03*
Cohabitation
  Living alone 66 (25) 16 (29) 43 (25) 7 (21)
  Cohabitant 196 (75) 40 (71) 129 (75) 27 (79) 0.70
Children  
  Yes 232 (89) 54 (96) 146 (85) 32 (94)
  No 30 (11) 2 (4) 26 (15) 2 (6) 0.51
*p-value < 0.05. For categorical variables, p-values were calculated with χ2 test for 
independence or Fisher’s exact test when expected cell frequencies were < 5. p-value 
calculated with one-way analysis of variance (ANOVA) for continuous variables (age). 
Tukey’s post-hoc test showed that there were no significant differences between active and 
remission groups, but between latent and both remission and active sub-groups.






PCT in remission 
Mean (95% CI)
Latent PCT 
Mean (95% CI) p-value Cronbach’s α
Brief Illness Perception Questionnaire (0–10) (n = 235–261) (n = 51–57) (n = 156–170) (n = 28–34)
  Consequences 3.2 (2.9–3.5) 4.9 (4.1–5.7) 2.9 (2.5–3.3) 1.6 (1.0–2.2) < 0.01*
  Timeline 8.1 (7.7–8.5) 8.8 (8.2–9.4) 8.0 (7.5–8.4) 7.3 (5.8–8.8) 0.05*
  Personal control 5.8 (5.5–6.2) 5.4 (4.7–6.2) 6.2 (5.7–6.6) 4.9 (3.4–6.3) 0.9
  Treatment control 7.5 (7.1–7.8) 7.6 (6.9–8.4) 7.7 (7.2–8.1) 6.1 (5.2–7.1) 0.02*
  Identity 2.9 (2.6–3.3) 5.8 (5.2–6.5) 2.6 (2.2–2.9) 0.2 (0.0–0.3) < 0.01*
  Concern 3.4 (3.0–3.7) 4.8 (4.0–5.6) 3.2 (2.8–3.6) 1.9 (1.2–2.7) < 0.01*
  Coherence 5.6 (5.2–6.0) 5.9 (5.2–6.6) 5.7 (5.2–6.1) 4.7 (3.7–5.7) 0.12
  Emotional response 2.9 (2.5–3.2) 4.4 (3.6–5.3) 2.7 (2.3–3.0) 1.3 (0.7–1.9) < 0.01*
  Overall score 31.5 (29.9–33.2) 39.6 (35.8–43.4) 29.7 (27.9–31.5) 27.2 (23.3–31.1) < 0.01* 0.67
Subjective health complaints (n = 255) (n = 56) (n = 166) (n = 33)
  Total sum score 15.1 (13.6–16.7) 20.5 (16.7–24.2) 14.1 (12.4–15.8) 10.7 (7.7–13.7) < 0.1* 0.88
Impact of Events Scale (n = 258) (n = 57) (n = 169) (n = 32)
  Intrusion (0–35) 7.0 (6.0–7.9) 11.7 (9.1–14.3) 6.1 (5.1–7.1) 3.0 (1.6–4.4) < 0.01* 0.93
  Avoidance (0–40) 7.2 (6.2–8.1) 12.1 (9.5–14.7) 6.1 (5.1–7.1) 4.3 (2.2–6.4) < 0.01* 0.85
Score above 0 on IES (n = 206/189) (n = 51/50) (n = 136/120) (n = 19)
  Intrusion 8.7 (7.7–9.7) 13.1 (10.5–15.8) 7.6 (6.5–8.6) 5.1 (3.1–7.0) < 0.01*
  Avoidance 9.8 (8.7–10.9) 13.8 (11.1–16.4) 8.6 (7.5–9.7) 7.3 (4.4–10.1) < 0.01*
p-values for differences between means calculated using the Welch analysis of variance (ANOVA). *p-value ≤ 0.05. PCT: porphyria cutanea tarda.
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DISCUSSION
The current study found a trend towards higher percei-
ved illness threat, more self-reported health complaints 
and more porphyria-related psychological distress in 
participants reporting active PCT compared with those 
reporting latent PCT or PCT in remission. However, 
the regression analysis did not support an association 
between PCT symptoms and higher scores on por phyria-
related distress. By contrast, perceived illness threat and 
total health complaints were associated with greater 
porphyria-related distress. 
The finding that perceived illness threat, and not 
reported symptoms activity, was associated with 
porphyria-related distress suggests that, although PCT 
symptoms can be dramatic, PCT in remission can also 
be challenging for patients. Exactly what it is that makes 
some patients view PCT as a threatening disease cannot 
be answered by the present study. In view of the results 
showing that total health complaints are associated with 
PCT-distress, and that our previous study (8) showed 
that PCT patients can find it difficult to separate PCT 
from other conditions, a possible explanation might be 
that health complaints other than skin symptoms are also 
thought to be caused by PCT, and this is contributing to 
patients reporting higher psychological distress. Others 
have shown that the perception of disease is associated 
with psychological distress and QoL in dermatological 
disorders (18–20), and despite the diverse aetiology, 
photodermatosis (21) can have a major impact on QoL 
(7), psychological well-being and lifestyle (22), which 
suggests that the management of photosensitivity disor-
ders requires a biopsychosocial approach (18, 23) and 
that further studies are warranted investigating how PCT 
in both active and remission phases impacts QoL.
In agreement with the findings of our previous study 
using focus groups (8), we found an overall high belief 
in the condition being chronic. This can be viewed as 
positive, in that it might increase compliance with the 
guidelines for control and preventive measures. Annual 
assessment of urinary porphyrin excretion, iron meta-
bolism and liver function are recommended (1). On the 
other hand, many patients with PCT are expected to 
experience life-long remission, and a high degree of per-
ceived chronicity and illness threat can entail an ethically 
challenging situation with a potential for medicalization 
of this group. Our previous study found evidence of over-
treatment; for example, frequent blood samples (every 
2 weeks and every month) in patients in remission (8). 
Participants with active PCT scored significantly higher 
on total self-reported health complaints compared with 
the remission and latent PCT groups. Various hepatic 
conditions, haemochromatosis and lifestyle factors, such 
as high alcohol intake and smoking, are associated with 
active PCT (1, 4, 24) and might contribute to explaining 
this finding in patients reporting active PCT. The finding 
that PCT is associated with other diseases may also have 
impacted on illness perception. Although data about this 
(i.e. alcoholism, hepatitis, etc.) was not investigated in 
the present study, the illness perception measurement 
(BIPQ) was porphyria specific and is expected to reflect 
the perception of PCT independent of other conditions. 
The socio-demographic differences between the PCT 
groups might also explain some of the observed diffe-
rences. Although there were more men than women in 
the active PCT group, women are generally known to 
report more substantial health complaints (25). An alter-
native explanation is that attribution of health complaints 
to PCT could have resulted in a “false” self-reported 
classification of PCT activity, which is consistent with 
the findings of our earlier study in which participants 
reported experiencing PCT as a systemic disease sus-
pected to cause a range of health complaints (8). The 
active PCT group also scored significantly higher on the 
identity item, indicating that this group attributed more 
symptoms to PCT.
Whether or not PCT is a distress-causing life-event, is 
debatable. Previous findings have, however, shown that 
PCT could certainly have a large negative psychosocial 
impact for some (8). In the present study, we did not use 
individual cut-off values to differentiate between distress 
and no distress, but rather tried to identify the factors as-
sociated with higher distress scores. Individual scores > 9 
on the IES subscales have been used as an indication of 
distress of a moderate character (26). Others have sug-
gested a total sum score of ≥ 40 as signifying a stressful 
event (27). Although these cut-off values are intended 
for assessment on an individual level, it is interesting to 
note that, as a group, those reporting active PCT had a 
mean score on the intrusion and avoidance subscales in 
the “moderate distress” category. 
A positive finding was that the total PCT sample repor-
ted relatively high scores on coherence (understanding 
of the condition) and personal control. A high belief in 
treatment control was also reported, and the remission 
group reported the greatest belief in treatment, which in-
dicates that they experienced their treatment as adequate 
and effective, which fits well with previous findings (8). 
Table III. Multiple linear regression analysis with Impact of Events 
Score (IES) as the outcome measure
Variable
Intrusion (n = 185) Avoidance (n = 168)
B 95% CI p-value B 95% CI p-value
Constant 2.25 1.14–4.57 0.02 2.37 1.12–5.01 0.02
Age 0.99 0.98–1.00 0.11 1.00 0.99–1.01 0.87
Sex 1.09 0.86–1.34 0.44 1.13 0.86–1.47 0.38
SHC total 1.02 1.01–1.03 < 0.01* 1.02 1.01–1.04 < 0.01*
BIPQ total 1.03 1.01–1.04 < 0.01* 1.01 1.00–1.32 0.04*
PCT symptoms 1.24 0.92–1.68 0.15 1.31 0.94–1.81 0.11
Adjusted R2 0.30 0.20
*p ≤ 0.05. The total model was significant (p < 0.001). Analysis was performed on 
log-transformed outcome variables. The estimates and confidence intervals (CI) 
presented in the table were back-transformed to the original units of measure. 
Participants scoring 0 on the IES subscales (Intrusion n = 57 and Avoidance 
n = 68) were removed from the regression analysis. SHC: Subjective Health 
Complaints; BIPQ: Brief Illness Perception Questionnaire.
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Compared with the personal control scores in those with 
contact dermatitis (mean 3.5) (19), the PCT patients had 
a greater belief in their own control of the condition.
The classification of participants into active PCT, PCT 
in remission, and latent PCT was based on self-reported 
information. Although this study was aimed specifically 
at exploring the subjective experiences of the participants 
and their own interpretation of their situation with regards 
to PCT, a dermatology-specific instrument and objective 
evaluation of symptoms could have strengthened the 
study. A response rate of 54% is somewhat low and can 
be viewed as a limitation in terms of representability. 
In the present study, PCT was perceived as a chronic 
condition with a high degree of treatment control. Alt-
hough persons reporting active PCT had more health 
complaints and perceived PCT as more threatening 
compared with those reporting latent PCT or PCT in 
remission, psychological distress was more closely as-
sociated with a higher perception of illness threat and 
the total burden of health complaints than were percei-
ved PCT symptoms. This has implications for clinical 
consultations with this patient group. It seems evident 
that PCT patients need clear and concise information 
and guidance with regards to what health complaints 
are caused by PCT.
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